Medicared For All Logo

Martin Hyzinski MD in Scranton, Pennsylvania

Home Pennsylvania Scranton

Martin Hyzinski MD has Hematology/oncology as his primary medical specialty. Their primary office is: 743 Jefferson Ave in Scranton, Pennsylvania. They attended Perelman School Of Med At The University Of Pennsylvania and graduated in 1979 (around 45 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.


Martin B Hyzinski MD Office Phone and Directions

Martin Hyzinski MD
743 Jefferson Ave
Scranton, Pennsylvania 18510
570-558-3020


Patient Ratings
Please rate your experience with Martin Hyzinski MD below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 570-558-3020


Enter a starting address:


Healthcare Info for Martin Hyzinski MD

Medical School: Perelman School Of Med At The University Of Pennsylvania
Graduation Year: 1979
The Primary Medical Specialty for Martin Hyzinski MD is listed as: Hematology/oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 45
PAC (PECOS ID)#: 2365401940
NPI #: 1467446112
NPI Created On: 09/08/2005
NPI Last Updated Listed as: 07/08/2007
Primary Taxonomy Code: 207R00000X
License Number:
M8024781E
Listed Gender: Male

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Highmark Health Insurance Company
  • Humana
  • Highmark Inc.
  • First Priority Health
  • Geisinger Health Plan
  • Geisinger Quality Options
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.


Services and Procedures include:

  1. Insertion of needle into vein for collection of blood sample
  2. Blood test, comprehensive group of blood chemicals
  3. Lactate dehydrogenase (enzyme) level
  4. Complete blood cell count (red cells, white blood cell, platelets), automated test
  5. Red blood count, manual test
  6. Blood test, clotting time
  7. Vaccine for influenza for injection into muscle
  8. Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
  9. Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
  10. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
  11. Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle
  12. Hormonal anti-neoplastic chemotherapy administration beneath the skin or into muscle
  13. Infusion of chemotherapy into a vein up to 1 hour
  14. Infusion of chemotherapy into a vein
  15. Established patient office or other outpatient visit, typically 5 minutes
  16. Established patient office or other outpatient visit, typically 15 minutes
  17. Initial hospital inpatient care, typically 70 minutes per day
  18. Administration of influenza virus vaccine
  19. Injection, denosumab, 1 mg
  20. Injection, dexamethasone sodium phosphate, 1 mg

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781006763

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28


Payments Total: $16

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783676689

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Hematology

Name of Drug #1: REBLOZYL

Open Associated Drug #1: 59572-711-01


Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest: Yes

Third party is a Charity:: No

Record ID:: 835947593

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: BioOncology

Name of Drug #1: Kadcyla

Open Associated Drug #1: 50242-087-01

Drug or Biological: Biological

Product Category #2: BioOncology

Name Of Drug #2:: Phesgo

Associated Drug #2: 50242-245-01


Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 834960253

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: HORMONE THERAPY

Name of Drug #1: ORGOVYX

Open Associated Drug #1: 72974-120-01


Payments Total: $25

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 812726899

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: KISQALI

Open Associated Drug #1: 0078-0860-01

Drug or Biological: Drug

Product Category #2: ONCOLOGY

Name Of Drug #2:: FEMARA

Associated Drug #2: 0078-0249-15

Drug or Biological #3:: Drug

Product Category #3: ONCOLOGY

Name of Drug: PIQRAY

Name Of Drug #3: 0078-0708-02

Drug or Biological: Drug

Product Category #4: ONCOLOGY

Name of Drug #4: SANDOSTATIN

Associated Drug #4: 0078-0181-01


Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 812726897

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: KISQALI

Open Associated Drug #1: 0078-0860-01

Drug or Biological: Drug

Product Category #2: ONCOLOGY

Name Of Drug #2:: FEMARA

Associated Drug #2: 0078-0249-15

Drug or Biological #3:: Drug

Product Category #3: ONCOLOGY

Name of Drug: PIQRAY

Name Of Drug #3: 0078-0708-02

Drug or Biological: Drug

Product Category #4: ONCOLOGY

Name of Drug #4: SANDOSTATIN

Associated Drug #4: 0078-0181-01


Payments Total: $25

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 812726901

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: KISQALI

Open Associated Drug #1: 0078-0860-01

Drug or Biological: Drug

Product Category #2: ONCOLOGY

Name Of Drug #2:: FEMARA

Associated Drug #2: 0078-0249-15

Drug or Biological #3:: Drug

Product Category #3: ONCOLOGY

Name of Drug: PIQRAY

Name Of Drug #3: 0078-0708-02


Payments Total: $100

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 812726903

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: KISQALI

Open Associated Drug #1: 0078-0860-01


Payments Total: $100

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 812726905

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: KISQALI

Open Associated Drug #1: 0078-0860-01


Payments Total: $100

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 812726907

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: KISQALI

Open Associated Drug #1: 0078-0860-01


Providers in the same medical group

1.Jon Aagaard

2001 N Gary Ave
Wheaton Il 60187-3055
Family Practice

2.Matthew Aaker

8055 W Ave
Castle Hills Tx 78213-1842
Optometry

3.Justin Aaker

3613 Williams Dr
Georgetown Tx 78628-1373
Ophthalmology

4.Mohammad Aalai

7005 35th Ave
Jackson Heights Ny 11372-3970
Physical Medicine And Rehabilitation

5.Carol Aalbers Cp

4560 S Carson St
Carson City Nv 89701-6915
Clinical Psychologist

6.Hina Aamir

602 S Atwood Rd
Bel Air Md 21014-4323
Psychiatry